glp 1 drugs and breast cancer for Glucagon-like peptide 1 receptor agonists cancer risk: advancing precision GLP-1 Receptor Agonists in Breast – GLP-1 reduces breast cancer mortality

Glutathione l s kt hp ca 3 axit amin (axit glutamic, cysteine v glycine) c sn xut trong gan v ng vai tr quan trng trong cc phn ng oxy ha kh trong c th

Jiang K, Moe-Lange J, Hennet L, Feldman LJ (2016) Salt stress affects the redox status of Arabidopsis root meristems

10.1007/s11095-013-1007-6 31 MeansS

Highest dose, obesity trial obesity-plus-diabetes trial (treatment-policy estimand): Semaglutide: 14.9% (STEP 1) 9.6% (STEP 2), a 5.3 point gap Tirzepatide: 20.9% (SURMOUNT-1) 14.7% (SURMOUNT-2), a 6.2 point gap Retatrutide: 25.0% (TRIUMPH-1) 20.8% (TRIUMPH-2 only efficacy-estimand currently reported so true gap is larger) It's still unclear the reason why we observe less weight loss in those with type 2 diabetes